The Phase 2a MASLD readout published in Nature Medicine in 2024 reported dose-dependent reductions in liver fat content across the same dose range (Sanyal et al., Nature Medicine, 2024)
Results: Several studies have discussed the CV beneficial effects of GLP-1 RAs in terms of reducing blood pressure, lipid levels, body weight, risk for arrhythmias, reducing the risk of major adverse CV events, and hospital admission for heart failure
Moving beyond the hype, we will cover: Shattering the Income Myth: The assumption that GLP-1 is a premium niche is dead
By stimulating insulin secretion and reducing glucagon release, semaglutide helps maintain optimal blood sugar levels
This article covers what glutathione is, its role in the body during pregnancy, and the safety considerations you should discuss with your healthcare provider